PCVX

Vaxcyte
D

PCVX

43.700
USD
1.70
(4.05%)
مغلق
حجم التداول
112,491
الربح لكل سهم
-4
العائد الربحي
-
P/E
-11
حجم السوق
5,673,280,614
الأخبار المقالات

العنوان: Vaxcyte

القطاع: Healthcare
الصناعة: Biotechnology
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to preventor treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.